Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought

Class:IdLiteratureReference:9756816
_displayNameCDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
_timestamp2021-10-18 18:06:35
author[Person:9756819] Klein, Mary E
[Person:9756812] Kovatcheva, Marta
[Person:9756813] Davis, Lara E
[Person:9680506] Tap, William D
[Person:8942640] Koff, Andrew
created[InstanceEdit:9756818] Orlic-Milacic, Marija, 2021-10-18
journalCancer Cell
pages9-20
pubMedIdentifier29731395
titleCDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
volume34
year2018
(literatureReference)[Pathway:9754119] Drug-mediated inhibition of CDK4/CDK6 activity [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (9756816)